Feedback / Questions
64/67Cu SAR-bisPSMA theranostic - Clarity Pharma
https://www.prnewswire.com/news-releases/first-patient-treated-in-claritys-cu-64cu-67-sar-bispsma-theranostic-prostate-cancer-trial-301362306.html
Aug 25, 2021
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next